Edwin M Meyer is a prominent inventor based in Gainesville, FL (US), known for his significant contributions to the field of gene transfer technologies. With a total of 5 patents, he has made remarkable strides in understanding and treating neurodegenerative diseases.

Latest Patents

One of his latest patents focuses on "Human disease modeling using somatic gene transfer." This invention provides a system for modeling neurodegenerative and other diseases through somatic gene transfer. In addition, it includes methods of multiple gene transfer, disease analysis, and drug testing. Another notable patent is for the "Use of nicotinic analogs for treatment of degenerative diseases of the nervous system." This patent outlines a method of using anabaseine, DMAB-anabaseine, and anabaseine for stimulating brain cholinergic transmission, along with a method of making anabaseine.

Career Highlights

Edwin M Meyer is affiliated with the University of Florida Research Foundation Inc., where he continues to advance research in gene transfer technologies. His work has been instrumental in developing innovative solutions for complex health issues.

Collaborations

He has collaborated with notable colleagues such as William Reade Kem and John A Zoltewicz, contributing to a rich environment of research and innovation.

Conclusion

Edwin M Meyer stands out as a key figure in the field of gene transfer technologies, with a focus on addressing neurodegenerative diseases through innovative methods. His contributions continue to pave the way for future advancements in medical research.